Page 669 - Bloomberg

India to see 'k-shaped' recovery as inequalities grow: ex-RBI governor

Duvvuri Subbarao says policymakers have limited to help the economy as India battles a second wave of Covid-19 cases.

India gold imports jump to near two-year high as weddings revive demand

Overseas purchases increased more than sevenfold to 98.6 tons last month from 13 tons a year earlier.

A wealth tax is a bad way to pay off pandemic debts: Nobel economist

Angus Deaton said that levies on high-earners would be 'very difficult to implement' and give the wealthy 'huge incentives to avoid it'

Yemeni Houthis claim drone attack on Saudi Aramco's oil facilities

While attacks on Saudi cities and energy installations have increased this year, they rarely claim lives or cause extensive damage

Covid: Brazilian phase 3 study shows China's Sinovac jab has 50.7% efficacy

The study, which was posted online and hasn't yet been reviewed by independent scientists, showed the vaccine was more effective at protecting against dangerous infections

India sees job losses as states impose lockdowns to check new Covid-19 wave

Unemployment touched 8.6% for the week ending April 11, from 6.7% two weeks ago, showed data by CMIE.

Joe Biden's aggressive climate plan puts pressure on China, India

India is world's third-biggest polluter and it has yet to publicly commit to a pathway toward net zero emissions.

Lopsided distribution: Wealthy countries getting vaccinated 25 times faster

In other words, countries with the highest incomes are vaccinating 25 times faster than those with the lowest

SBI drags feet on loan to Adani firm for controversial Australian coal mine

Bank's executive committee, which will make the final decision, hasn't had discussions about the loan this year, reports Bloomberg.

For the rich, living in Asia costlier than anyplace; Shanghai priciest city

Asian cities are more expensive partly because "Covid didn't become an epidemic quite the same way it unfortunately became in the other cities in the index"

China's bid to ramp up Covid vaccinations hindered by supply shortages

China has also offered vaccines to the International Olympics Committee for the upcoming Tokyo Games, while carrying out discussions with European countries looking for supply

State-run refiners prepare to buy Iran oil once US sanctions ease

India has been vocal in its support for Iranian crude purchases recently as it laments the price of supplies from Saudi Arabia.

Saudi Arabia crown prince's past makes his vision a tough sell abroad

His plan to open up the economy may be jeopardised by his reputation

US offer on global corporate tax deal would tie levies to revenue

OECD is trying to forge a deal among 139 countries on its plan by this summer

Federal Reserve signals intent to wield power over short-term rates

Repo and Treasury bill rates have been flirting with zero since the beginning of the year as reserve balances at the central bank swell

US jobless claims jump to 744,000 as Covid-19 still forces layoffs

Initial claims in regular state programs increased by 16,000 to 744,000 in the week ended April 3, Labor Department data showed Thursday. Economists in a Bloomberg survey estimated 680,000 claims

GameStop shares rise over plan to replace chairman with Ryan Cohen

Kurtis Wolf resigned effective April 5, GameStop said in a filing Thursday. The company said the resignation didn't result from a disagreement over operations, policies or practices

Credit Suisse CEO Gottstein faces anger in the ranks on Archegos mess

According to people with knowledge of the call, Gottstein was grilled on the exposure and risk profile of the bank -- and why it lost so much more than rivals in the debacle

Amazon reveals scorching growth in India as Flipkart fight deepens

The US online giant said it has enabled exports of Indian-made goods worth $3 billion and created over a million local jobs since it began operating in the Asian nation about a decade ago

AstraZeneca blood clot worries complicate bid to vaccinate the world

Reviews by UK and EU regulators finding potential links to the unusual side effects are another blow for the shot, a cheaper and easier-to-deploy product that many nations are counting on